BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12203663)

  • 1. Is epoetin alfa a treatment option for chemotherapy-related anemia in children?
    Büyükpamukçu M; Varan A; Kutluk T; Akyüz C
    Med Pediatr Oncol; 2002 Oct; 39(4):455-8. PubMed ID: 12203663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early epoetin alfa treatment in children with solid tumors.
    Zoubek A; Kronberger M
    Med Pediatr Oncol; 2002 Oct; 39(4):459-62. PubMed ID: 12203664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new induction schedule of epoetin alfa 40.000 IU in anemic patients with advanced lung cancer.
    Ariganello O; Mancuso A; Di Molfetta M; Diana F; Beccaglia P; Cortesi E; De Marinis F
    Lung Cancer; 2004 Oct; 46(1):119-24. PubMed ID: 15364140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
    Patton J; Kuzur M; Liggett W; Miranda F; Varsos H; Porter L
    Oncologist; 2004; 9(1):90-6. PubMed ID: 14755018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for anemia in pediatric cancer patients.
    Ruggiero A; Riccardi R
    Med Pediatr Oncol; 2002 Oct; 39(4):451-4. PubMed ID: 12203662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the efficacy and safety of fixed versus weight-based dosing of epoetin alpha in anemic cancer patients receiving platinum-based chemotherapy.
    Granetto C; Ricci S; Martoni A; Pezzella G; Testore F; Mattioli R; Lampignano M; Tacconi F; Porrozzi S; Gasparini G; Mantovani G;
    Oncol Rep; 2003; 10(5):1289-96. PubMed ID: 12883695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N; Sriuranpong V; Suwanrusme H
    J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
    Biesma B; van de Werf PR; Melissant CF; Brok RG
    Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.
    Witzig TE; Silberstein PT; Loprinzi CL; Sloan JA; Novotny PJ; Mailliard JA; Rowland KM; Alberts SR; Krook JE; Levitt R; Morton RF
    J Clin Oncol; 2005 Apr; 23(12):2606-17. PubMed ID: 15452187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy.
    Chang J; Couture F; Young S; McWatters KL; Lau CY
    J Clin Oncol; 2005 Apr; 23(12):2597-605. PubMed ID: 15452188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy.
    Shasha D; George MJ; Harrison LB
    Cancer; 2003 Sep; 98(5):1072-9. PubMed ID: 12942577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human erythropoietin and platinum-based chemotherapy in advanced ovarian cancer.
    Welch RS; James RD; Wilkinson PM; Belli F; Cowan RA
    Cancer J Sci Am; 1995; 1(4):261-6. PubMed ID: 9166486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level.
    Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
    Oncologist; 2006 Feb; 11(2):206-16. PubMed ID: 16476841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy.
    Littlewood TJ; Nortier J; Rapoport B; Pawlicki M; de Wasch G; Vercammen E; Schuette W; Wils J; Freund M;
    Hematol Oncol; 2003 Dec; 21(4):169-80. PubMed ID: 14735555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients previously transfused or treated with epoetin alfa at low baseline hemoglobin are at higher risk for subsequent transfusion: an integrated analysis of the Canadian experience.
    Quirt I; Kovacs M; Couture F; Turner AR; Noble M; Burkes R; Dolan S; Plante RK; Lau CY; Chang J
    Oncologist; 2006 Jan; 11(1):73-82. PubMed ID: 16401716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation of epoetin-alpha therapy at a starting dose of 120,000 units once every 3 weeks in patients with cancer receiving chemotherapy: an open-label, multicenter study with randomized and nonrandomized treatment arms.
    Glaspy JA; Charu V; Luo D; Moyo V; Kamin M; Wilhelm FE
    Cancer; 2009 Mar; 115(5):1121-31. PubMed ID: 19170225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
    Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
    Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
    Corapcioglu F; Aksu G; Basar EZ; Demirel A; Oncel S; Mutlu A
    Pediatr Hematol Oncol; 2008 Sep; 25(6):509-21. PubMed ID: 18728970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy.
    Schouwink JH; Codrington H; Sleeboom HP; Kerkhofs LG; Wormhoudt LW
    Eur J Cancer; 2008 Apr; 44(6):819-29. PubMed ID: 18343652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.